Dow futures in red ahead of August PPI data: 5 things to know before Wall Street opens

Markets are cautiously awaiting August's Producer Price Index (PPI) data, expected to show a 0.3% monthly increase, as investors gauge inflation trends and the Federal Reserve's next interest rate decision. Dow futures are slightly down, reflecting this uncertainty, while tech stocks like Oracle have surged over 20% on strong AI-driven multi-cloud database revenue growth, contrasting with declines in healthcare shares due to weak outlooks. The PPI report is critical, as a hotter-than-expected reading could delay rate cuts, influencing global investment flows and determining the sustainability of recent market rallies.

Analysis

The market is exhibiting a cautious and divergent posture ahead of the August Producer Price Index (PPI) report, a critical data point that will inform the Federal Reserve's next policy move. Pre-market activity shows Dow futures declining while the tech-heavy Nasdaq is advancing, underscoring a split in investor sentiment. This divergence is driven by sector-specific news; the technology sector is buoyed by Oracle, which surged over 20% after reporting a 1,500% year-over-year increase in multicloud database revenue fueled by AI demand. In stark contrast, the healthcare sector is under significant pressure, with Walgreens Boots Alliance tumbling on a revenue warning and CVS Health declining due to a weak outlook. With economists expecting a 0.3% monthly increase in PPI, any deviation from this consensus is poised to be a major market catalyst, potentially breaking the S&P 500 from its narrow trading range and determining whether the Nasdaq can overcome resistance near the 24,250 level.

Key Decisions for Investors

• Investors should prepare for heightened volatility around the August PPI data release; a figure hotter than the 0.3% consensus could dampen expectations for Fed rate cuts and trigger a broad market sell-off, while an in-line or softer reading could sustain the current rally.
• Consider overweighting exposure to technology companies with strong fundamental catalysts in high-growth areas like AI, exemplified by Oracle's performance, while potentially reducing or hedging positions in consumer-facing healthcare stocks like Walgreens and CVS that are issuing negative guidance.
• Monitor key technical levels for major indexes, such as the 24,250 resistance for the Nasdaq and the 6,490-6,512 range for the S&P 500, as a decisive break following the inflation report could confirm the market's next directional leg.